Literature DB >> 25303760

Applicability of the prevention protocol of pressure ulcers in intensive care unit.

Emanuelly Wedja do Nascimento Lima E Silva1, Raquell Alves de Araújo1, Elizandra Cássia de Oliveira1, Viviane Tannuri Ferreira Lima Falcão2.   

Abstract

OBJECTIVE: The avoidance of pressure ulcers development in critically ill patients is a major nursing challenge. Prevention is thus relevant for assurance of high quality care. This study aimed to evaluate the applicability of the Braden scale in intensive care unit patients.
METHODS: This was a prospective study based which evaluated all adult patients staying in the intensive care unit from July 14 to August 10, 2009. The data were collected using the Braden's scale by three examiners who identified the pressure ulcer development risk. The data were analyzed using the SAS Statistical Software. For determination of the examiners' rates degree of coincidence, the Kappa value was used (95%CI).
RESULTS: Regarding the related risk factors: 36.4% had mild sensory perception impairment; 50.9% had occasionally moist skin; 97.3% bedfast; 39.1% had very limited mobility; 45% probably had inappropriate nutrition; 61.8% had friction and shear problems. An agreement between the examiners was identified for nutrition and physical activity (38.1% to 100.0%); the Kappa population zero hypothesis was rejected; a paired examiners agreement (41.7% to 100.0%) was identified for the items humidity and physical activity, and the Kappa values ranged from 0.13 to 1.
CONCLUSIONS: These intensive care patients were identified to have increased risk of developing pressure ulcers. This tool was considered appropriate to support the implementation of preventive measures.

Entities:  

Year:  2010        PMID: 25303760

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  1 in total

1.  Relationship between Braden scale score and pressure ulcer development in patients admitted in trauma intensive care unit.

Authors:  Sedigheh Iranmanesh; Hossein Rafiei; Sakineh Sabzevari
Journal:  Int Wound J       Date:  2011-09-13       Impact factor: 3.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.